The Second Epidemiologic Transition from an Epidemiologist's Perspective

Modern Environments and Human Health: Revisiting the Second Epidemiologic Transition

Volumn , Issue , 2014, Pages 353-368

  Fleischer, Nancy L ^a   Mckeown, Robert E ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Epidemiologic transition theory; Epidemiologic triangle; Epidemiologists; Noncommunicable diseases (NCDs); Second epidemiologic transition; Social epidemiology

Indexed keywords

EID: 84927136020     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118504338.ch19     Document Type: Chapter

References (71)

1. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. 2007. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 370(9603):1929-1938.
2. Anderson RN. 1999. Method for constructing complete annual U.S. life tables. Vital health statistics, series 2, Data Evaluation and Methods Research, No. 129. Hyattsville: National Center for Health Statistics.
3. Armelagos GJ, Brown PJ, Turner B. 2005. Evolutionary, historical and political economic perspectives on health and disease. Soc Sci Med 61(4):755-765.
4. Beaglehole R, Yach D. 2003. Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults. Lancet 362(9387):903-908.
5. Berkman LF, Kawachi I, editors. 2000. Social epidemiology. New York: Oxford University Press.
6. Boutayeb A. 2006. The double burden of communicable and non-communicable diseases in developing countries. Trans R Soc Trop Med Hyg 100(3):191-199.
7. Caldwell JC. 2001. Population health in transition. Bull World Health Org 79(2):159-160.
8. Caselli G, Mesle F, Vallin J. 2002. Epidemiologic transition theory exceptions. Genus 9:9-51.
9. Cassel J, Heyden S, Bartel AG, et al. 1971. Incidence of coronary heart disease by ethnic group, social class, and sex. Arch Intern Med 128(6):901-906.
10. Diez-Roux AV. 1998. Bringing context back into epidemiology: variables and fallacies in multilevel analysis. Am J Public Health 88(2):216-222.
11. Diez-Roux AV. 2007. Integrating social and biologic factors in health research: a systems view. Ann Epidemiol 17(7):569-574.
12. Diez-Roux AV. 2011. Complex systems thinking and current impasses in health disparities research. Am J Public Health 101(9):1627-1634.
13. Editors. 1942. What and who is an epidemiologist? Am J Public Health 32(April):414-415.
14. Gage TB. 2005. Are modern environments really bad for us?. Revisiting the demographic and epidemiologic transitions. Yearb Phys Anthropol 48:96-117.
15. Gaylin DS, Kates J. 1997. Refocusing the lens: epidemiologic transition theory, mortality differentials, and the AIDS pandemic. Soc Sci Med 44(5):609-621.
16. Graziano JM. 2010. Fifth phase of the epidemiologic transition: the age of obesity and inactivity. JAMA 303(3):275-276.
17. Greenhalgh S, Montgomery M, Segal S, Todaro MP, UN Population Fund. 2007. State of world population 2007: unleashing the potential of urban growth. Popul Dev Rev 33:639-640.
18. Harper K, Armelagos GJ. 2010. The changing disease-scape in the third epidemiological transition. Int J Environ Res Public Health 7:675-697.
19. Holloway K, Henneberg R, Lopes M, et al. 2013. Secular trends in tuberculosis during the second epidemiological transition: a Swiss perspective. Adv Anthropol 3:78-90.
20. Institute of Medicine and Committee on Assuring the Health of the Public in the 21st Century. 2003. The future of the public's health in the 21st century. Washington, DC: National Academy Press.
21. Johnson S. 2006. The ghost map: The story of London's most terrifying epidemic - and how it changed science, cities and the modern world. New York: Riverhead Books.
22. Kaplan GA, Keil JE. 1993. Socioeconomic-factors and cardiovascular-disease - a review of the literature. Circulation 88(4):1973-1998.
23. Kawachi I, Berkman LF, editors. 2003. Neighborhoods and health. New York: Oxford University Press.
24. Keith S, Redden DK, Katzmarzyk PT, et al. 2006. Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes 30:1585-1594.
25. King H, Aubert RE, Herman WH. 1998. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21(9):1414-1431.
26. Klimentidis Y, Beasley T, Lin H, et al. 2011. Canaries in the coal mine: a cross-species analysis of the plurality of obesity epidemics. Proc R Soc Biol Sci 278(1712):1626-1632.
27. Krieger N. 1994. Epidemiology and the web of causation: has anyone seen the spider?. Soc Sci Med 39:887-903.
28. Krieger N. 2001a. A glossary for social epidemiology. J Epidemiol Community Health 55:693-700.
29. Krieger N. 2001b. Theories for social epidemiology in the 21st century: an ecosocial perspective. Int J Epidemiol 30:668-677.
30. Kuhn TS. 1970. The structure of scientific revolutions. Chicago: University of Chicago Press.
31. Leeder S, Raymond S, Greenberg H, Liu H, Esson K. 2004. A race against time: The challenge of cardiovascular disease in developing economies. New York: Columbia University.
32. Mabry PL, Olster DH, Morgan GD, Abrams D. 2008. Interdisciplinary and systems science to improve population health: a view from the NIH Office of Behavioral and Social Science Research. Am J Prev Med 35(2S):S211-S224.
33. Mackenbach JP. 1994. The epidemiologic transition theory. J Epidemiol Community Health 48(4):329-331.
34. MacMahon B, Pugh TF, Ipsen J. 1960. Epidemiologic methods. Boston: Little Brown & Co.
35. Mathers CD, Loncar D. 2006. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3(11):e442.
36. McKeown RE. 2009. The epidemiologic transition: changing patterns of mortality and population dynamics. Am J Lifestyle Med 3(1 Suppl):19S-26S.
37. McKeown RE. 2013a. What's an epidemiologist to do? Epidemiology 23(6):923-926.
38. McKeown RE. 2013b. Is epidemiology correcting its vision problem? A perspective on our perspective: 2012 presidential address for American College of Epidemiology. Ann Epidemiol 23(10):603-607.
39. Murphy S, Xu J, Kochanek K. 2013. Deaths: Final data for 2010 National Vital Statistics Reports. Hyattsville: National Center for Health Statistics.
40. Murray CJ, Abraham J, Ali MK, et al. 2013. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 310:591-608.
41. National Research Council (NRC), Committee on a Framework for Development of a New Taxonomy of Disease. 2011. Toward precision medicine: Building a knowledge network for biomedical research and a new taxonomy of disease. Washington, DC: National Academies Press.
42. Oakes JM, Kaufman JS, editors. 2006. Methods in social epidemiology. San Francisco: Jossey-Bass.
43. Olshansky SJ, Ault AB. 1986. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Q 64(3):355-391.
44. Olshansky SJ, Carnes BA, Rogers RG, Smith L. 1998. Emerging infectious diseases: the fifth stage of the epidemiologic transition? World Health Stat Q 51(2-4):207-217.
45. Omran AR. 1971. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q 49(4):509-538.
46. Omran AR. 1977. A century of epidemiologic transition in the United States. Prev Med 6(1):30-51.
47. Pearson TA. 2003. Education and income: double-edged swords in the epidemiologic transition of cardiovascular disease. Ethn Dis 13(S2):S158-S163.
48. Phillips DR. 1993. Urbanization and human health. Parasitology 106:S93-S107.
49. Popkin BM. 2006. Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases. Am J Clin Nutr 84(2):289-298.
50. Porta M. 2008. A dictionary of epidemiology. 5th ed. Oxford: Oxford University Press.
51. Reddy KS. 1999. Emerging epidemic of cardiovascular disease in the developing countries. Atherosclerosis 144:143.
52. Reddy KS, Yusuf S. 1998. Emerging epidemic of cardiovascular disease in developing countries. Circulation 97(6):596-601.
53. Rockett IRH. 1999. Population and health: An introduction to epidemiology. 2nd ed. Washington, DC: Population Bulletin.
54. Sanders JW, Fuhrer GS, Johnson MD, Riddle MS. 2008. The epidemiological transition: the current status of infectious diseases in the developed world versus the developing world. Sci Prog 91(Pt 1):1-37.
55. Smallman-Raynor M, Phillips D. 1999. Late stages of epidemiological transition: health status in the developed world. Health Place 5(3):209-222.
56. Stallones RA. 1966. Prospective epidemiologic studies of cerebrovascular disease. Washington, DC: U.S. Government Printing Office.
57. Strong K, Mathers C, Leeder S, Beaglehole R. 2005. Preventing chronic diseases: how many lives can we save?. Lancet 366(9496):1578-1582.
58. Sulsky SI, Kreiger N, McKeown RE. 2012. Not continuing along previous lines: exploring how new directions emerge in epidemiologic research. Ann Epidemiol 22(5):369-371.
59. Susser M. 1985. Epidemiology in the United States after World War II: the revolution of technique. Epidemiol Rev 7:147-177.
60. Susser M, Susser E. 1996a. Choosing a future for epidemiology: I. Eras and paradigms. Am J Public Health 86(5):668-673.
61. Susser M, Susser E. 1996b. Choosing a future for epidemiology: II. From black box to Chinese boxes and eco-epidemiology. Am J Public Health 86(5):674-677.
62. United Nations. 2007. World population ageing. New York: United Nations Department of Economic and Social Affairs.
63. Wheeler RE. 1942. Letter: what and who is an epidemiologist?. Am J Public Health 32(7):759-760.
64. WHO. 2002. The world health report 2002: Reducing risks, promoting healthy life. Geneva: World Health Organization.
65. WHO. 2008. The global burden of disease: 2004 update. Geneva: World Health Organization.
66. WHO. 2009. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization.
67. Wilkinson RG. 1994. The epidemiological transition: from material scarcity to social disadvantage?. Daedalus 123(4):61-77.
68. Winkelstein W, French FE, editors. 1972. Basic readings in epidemiology. 3rd ed. New York: MSS Educational Publishing Co.
69. Yach D, Hawkes C, Gould CL, Hofman KJ. 2004. The global burden of chronic diseases - overcoming impediments to prevention and control. JAMA 291(21):2616-2622.
70. Yusuf S, Reddy S, Ounpuu S, Anand S. 2001a. Global burden of cardiovascular diseases - part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104(23):2855-2864.
71. Yusuf S, Reddy S, Ounpuu S, Anand S. 2001b. Global burden of cardiovascular diseases - part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104(22):2746-2753.